Skip to main content
. 2017 Mar 1;7(3):484–502.

Table 5.

Analysis on ARID1A immunohistochemistry status in the ampullary tumors group

Characteristics ARID1A loss or weak staining (n=10) ARID1A positive staining (n=48) p-valuea
Age at surgery (yrs), median [range] 54.0 [38.0-71.0] 67.5 [41.0-79.0] 0.04
Gender (n, %)
    Female 6 (60.0%) 19 (39.6%) 0.30
    Male 4 (40.0%) 29 (60.4%)
Differentiation degree (n, %) 0.29
    G1, G1-G2 2 (20.0%) 11 (22.9%)
    G2, G2-G3 5 (50.0%) 30 (62.5%)
    G3 3 (30.0%) 5 (10.4%)
    Unknownb 0 (0.0%) 2 (4.2%)
pN (n, %) 0.29
    N0 5 (50.0%) 33 (68.75%)
    N1 5 (50.0%) 15 (31.25%)
pT (n, %) 0.87
    T1 1 (10.0%) 7 (14.6%)
    T2 5 (50.0%) 19 (39.6%)
    T3 3 (30.0%) 19 (39.6%)
    T4 1 (10.0%) 3 (6.3%)
Tumor size (cm), median [range] 2.5 [1.0-3.0] 2.0 [0.4-10.0] 0.57
Status (n, %)
    Alive 5 (50.0%) 27 (56.2%) 1.0
    Dead 4 (40.0%) 21 (43.8%)
    Unknownb 1 (10.0%) 0 (0.0%)
Overall survival (months), median [range] 39.2 [1.64-127.9] 24.9 [0.39-160.3] 0.37
ARID1A IHC subtype (n, %)
    Pancreatobilliary 3 (30.0%) 21 (43.8%) 0.59
    Intestinal 5 (50.0%) 18 (35.7%)
    Ambigous 1 (10.0%) 9 (18.8%)
    Unknownb 1 (10.0) 0 (0.0%)
a

differences between age and tumor sizes were calculated by means of Mann-Whitney test; differences in overall survival were calculated by means of Log-Rank Mantel Cox test; the rest were tested by Fisher exact t-test or Chi-square test;

b

not included in p-value calculation.